Analysts Predict Up to ~450% Surge for These 2 ‘Strong Buy’ Penny Stocks
Some of the market’s biggest winners start off as the smallest players. While trillion-dollar tech giants like the ...
Rare Disease Patients Face Barriers in Access and Care
An FDA-approved medication can now treat Friedreich's ataxia, but health plan barriers and formulary exclusions keep many patients from receiving it.
Independent.ie5d
Around the Districts: Dunlavin, Hollywood and Kiltegan
The 200-page journal includes an article about the massacre on Dunlavin green in 1798, and other articles on Hollywood, ...
DVLA lists every condition you need to declare or face £1,000 fine
It warns: "You need to tell DVLA about some medical conditions as they can affect your driving. You can be fined up to £1,000 ...
Jupiter Neurosciences says volatility ‘appears to be driven by misconceptions’
Jupiter Neurosciences (JUNS) issued a statement regarding recent market volatility and highlighted its planned Direct-to-Consumer product ...
Jupiter Neurosciences Addresses Market Volatility as it Remains Focused on Advancing Clinical and Commercial Milestones
Jupiter, Florida, Feb. 04, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage pharmaceutical company developing JOTROL™, a patented resveratrol-based platform, ...
PTC Therapeutics' SWOT analysis: stock poised for growth amid regulatory challenges
PTC Therapeutics, Inc. (NASDAQ:PTCT), a biopharmaceutical company focused on developing and commercializing novel medicines for rare disorders, finds itself at a critical juncture. With a promising ...